DiaTEC new purification technology Ingelvac CircoFLEX

Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX ®Ingelvac CircoFLEX ® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine to address two critical swine pathogens in one injection.With DiaTEC, a new and proprietary diafiltration technology, Ingelvac CircoFLEX ® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.Since its launch, Ingelvac CircoFLEX ® has been used to protect 3 billion pigs in more than 68 countries around the world, based on vaccine sales.

Source: Boehringer Ingelheim Corporate News - January 3, 2020 Category: Research Source Type: news